<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJTS</journal-id><journal-title-group><journal-title>Open Journal of Thoracic Surgery</journal-title></journal-title-group><issn pub-type="epub">2164-3059</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojts.2016.64006</article-id><article-id pub-id-type="publisher-id">OJTS-71857</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Incidence Risk and Independent Predictors of Prolonged Air Leak in 269 Consecutive Pulmonary Resection Patients over Nine Months: A Single-Center Retrospective Cohort Study
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Connie</surname><given-names>Drewbrook</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Samarpita</surname><given-names>Das</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dorsa</surname><given-names>Mousadoust</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dorsa</surname><given-names>Mousadoust</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dorsa</surname><given-names>Mousadoust</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Basil</surname><given-names>Nasir</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>John</surname><given-names>Yee</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Anna</surname><given-names>McGuire</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Faculty of Medicine, University of British Columbia, Vancouver, Canada</addr-line></aff><aff id="aff2"><addr-line>Department of Surgery, Division of Thoracic Surgery, University of British Columbia, Vancouver, Canada</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>conndrew@gmail.com(CD)</email>;<email>anna.mcguire@vch.ca(AM)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>11</month><year>2016</year></pub-date><volume>06</volume><issue>04</issue><fpage>33</fpage><lpage>46</lpage><history><date date-type="received"><day>October</day>	<month>12,</month>	<year>2016</year></date><date date-type="rev-recd"><day>Accepted:</day>	<month>November</month>	<year>6,</year>	</date><date date-type="accepted"><day>November</day>	<month>9,</month>	<year>2016</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction: Prolonged air leak (PAL) is a common complication following pulmonary resection. It is associated with pneumonia, empyema, increased length of hospital stay and health-care costs. Intraoperative techniques have been developed to mitigate the risk of developing a PAL, but for their use to be efficient, identification of patients at risk for PAL is necessary. Aim: To determine the incidence of PAL following lobectomy and lesser pulmonary resections, risk factors for development of PALs, and the impact of PAL on hospital stay and readmission rates. Methods: The following variables were analyzed as PAL risk factors: patient characteristics of age, sex, body mass index (BMI), forced minute expiratory volume and capacity ratio (FEV1 and FEV1/FVC), diffusion capacity (DCLO), and transplant recipient status. Validated scoring systems included the Charlson Comorbidity Index (CCI), Medical Research Council (MRC) dyspnea score, and Eastern Cooperative Oncology Group (EGOC) score. Surgical factors included surgical technique, unplanned conversion from video-assisted thoracoscopic surgery (VATS) to thoracotomy, location and extent of resection, presence of adhesions, completeness of fissures, and method of fissure completion. Length of hospital stay and readmission rates were analyzed. Statistical tests performed on the data include univariate and multivariate logistic regression analyses. Results: Over the 9-month study duration there were 269 lung resections, of which 31 (11.52%) had an air leak lasting longer than 5 days. Mean length of stay in hospital was significantly longer in patients with PAL compared to the control group (13 vs 5 days, 
  <em>P</em> &lt; 0.001). Significant risk factors for PAL from multivariate analysis include normal BMI (
  <em>P</em> = 0.009), right upper lobectomy (
  <em>P</em> = 0.001), and unplanned conversion from video-assisted thoracoscopic surgery (VATS) to thoracotomy (
  <em>P</em> = 0.023). Conclusion: The incidence of PAL in our study population is similar to that found in previous studies. PAL prolongs hospital length of stay. Normal BMI, right upper lobectomy, and unplanned conversion from VATS to thoracotomy are risk factors for PAL.
 
</p></abstract><kwd-group><kwd>Pulmonary Resection</kwd><kwd> Air Leak</kwd><kwd> Risk Factors</kwd><kwd> Length of Stay</kwd><kwd> Thoracic Surgery</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Air leak following pulmonary resection is a common problem and in most cases is due to an alveolar-pleural fistula [<xref ref-type="bibr" rid="scirp.71857-ref1">1</xref>] . The definition of a prolonged air leak (PAL) varies in the literature, but the currently accepted definition is an air leak lasting 5 or more days postoperatively [<xref ref-type="bibr" rid="scirp.71857-ref2">2</xref>] which is the average length of stay (LOS) in hospital following lobectomy [<xref ref-type="bibr" rid="scirp.71857-ref3">3</xref>] . In previous studies, PAL has been found to occur in up to 26% of patients following lobectomy and lesser pulmonary resections [<xref ref-type="bibr" rid="scirp.71857-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref8">8</xref>] .</p><p>The most consistent risk factors for PAL in the literature are related to reduced pulmonary function due to chronic obstructive pulmonary disease [<xref ref-type="bibr" rid="scirp.71857-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref12">12</xref>] . Additional risk factors that have been described include reduced diffusing capacity [<xref ref-type="bibr" rid="scirp.71857-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref12">12</xref>] , upper resections or bilobectomy [<xref ref-type="bibr" rid="scirp.71857-ref5">5</xref>] , pleural adhesions [<xref ref-type="bibr" rid="scirp.71857-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref12">12</xref>] , relatively lower BMI [<xref ref-type="bibr" rid="scirp.71857-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref14">14</xref>] , increased dyspnea score [<xref ref-type="bibr" rid="scirp.71857-ref14">14</xref>] , concurrent pneumothorax [<xref ref-type="bibr" rid="scirp.71857-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref10">10</xref>] , lobectomy [<xref ref-type="bibr" rid="scirp.71857-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref14">14</xref>] , preoperative inhaled or systemic steroid use [<xref ref-type="bibr" rid="scirp.71857-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref15">15</xref>] , radiologic findings of severe emphysema [<xref ref-type="bibr" rid="scirp.71857-ref8">8</xref>] , and histopathologic findings of emphysema [<xref ref-type="bibr" rid="scirp.71857-ref8">8</xref>] .</p><p>In most cases PAL is self-limited [<xref ref-type="bibr" rid="scirp.71857-ref10">10</xref>] , but it is associated with increased postoperative morbidity through increased rates of pulmonary and pleural complications such as empyema, pneumonia, and atelectasis [<xref ref-type="bibr" rid="scirp.71857-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref9">9</xref>] . Furthermore, the impact on the health- care system is significant as it prolongs hospital stay by 4 to 13 days [<xref ref-type="bibr" rid="scirp.71857-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref16">16</xref>] and as a result increases health-care costs [<xref ref-type="bibr" rid="scirp.71857-ref17">17</xref>] .</p><p>Due to the clinical implications of PAL, intraoperative methods have been developed to mitigate this risk and include pleural tenting, pneumoperitoneum, staple-line buttressing, and surgical sealants [<xref ref-type="bibr" rid="scirp.71857-ref18">18</xref>] . These techniques are not recommended to be performed routinely as not all patients are expected to benefit from their use [<xref ref-type="bibr" rid="scirp.71857-ref19">19</xref>] . Additionally, they are more time consuming and costly [<xref ref-type="bibr" rid="scirp.71857-ref19">19</xref>] . In order to identify patients at increased risk of PAL who may benefit from the use of intraoperative preventative techniques, several studies have identified risk factors for PAL and devised scoring systems to risk stratify patients [<xref ref-type="bibr" rid="scirp.71857-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref14">14</xref>] .</p><p>The aim of this retrospective cohort study is to investigate the incidence of PAL following pulmonary resection and the most common risk factors for PAL in this group of patients. Risk factor categories include patient characteristics, validated scoring methods, and surgical factors. The Charlson Comorbidity Index (CCI) was developed as a weighted index of comorbid disease [<xref ref-type="bibr" rid="scirp.71857-ref20">20</xref>] and has been found to be a strong predictor of major complications following surgery for patients with non-small cell lung cancer [<xref ref-type="bibr" rid="scirp.71857-ref21">21</xref>] . We plan to investigate whether the CCI can be used as a predictor for PAL following resection.</p></sec><sec id="s2"><title>2. Materials and Methods</title><p>All lobectomies and lesser resections performed at Vancouver General Hospital from October 2015 to July 2016 were included in the study. Inclusion criteria includes inpatients on the thoracic surgery ward, aged 18 and older, who have undergone pulmonary resection for benign or malignant causes. Patients who underwent pneumonectomy were excluded. Ethics approval was provided by the UBC Clinical Research Ethics Board.</p><p>Prospectively collected patient information was retrospectively obtained from the electronic medical record and hospital chart, and consisted of a patient’s history and physical examination, MRC dyspnea score [<xref ref-type="bibr" rid="scirp.71857-ref22">22</xref>] , ECOG score [<xref ref-type="bibr" rid="scirp.71857-ref23">23</xref>] , pulmonary function tests, operation report, and pathology report.</p><p>Patient information collected included sex, age, BMI, Charlson Comorbidities, smok- ing status, alcoholism, FEV and FVC volumes and percent predicted, FEV/FVC ratio, diffusing capacity (DLCO), location and type of resection, presence of adhesions, completeness of fissures, method of completion for incomplete fissures, histology, TNM staging for non-small cell lung cancers, and primary diagnosis. The CCI is calculated as a weighted sum of 19 retrospectively collected patient comorbid conditions [<xref ref-type="bibr" rid="scirp.71857-ref20">20</xref>] . There were no patients with hemiplegia, moderate to severe liver disease, or AIDS, so these categories were not included in the analysis.</p><p>Pulmonary resections were performed by one of three thoracic surgeons at Vancouver General Hospital by video-assisted thoracoscopic surgery (VATS), thoracotomy, or midline sternotomy. Incomplete fissures were mainly completed with a stapler, although in a minority of cases electrocautery or a combination of electrocautery and staples were used.</p><p>One or two chest tubes were inserted and connected to a Pleur-Evac (Teleflex Medical, Wayne, PA) or Topaz (Medela, Baar, Switzerland) digital drainage device. The definition used for PAL was an air leak lasting 5 or more days.</p><p>Statistical analysis was performed using Stata 12 statistical software. Categorical variables were analyzed using the chi square test or Fisher exact test, whereas, continuous variables were analyzed using the two-tailed t-test. Univariate and multivariate analyses were performed. A P-value of &lt;0.05 was considered significant.</p></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Patient Characteristics</title><p>Over the 9-month duration of the study there were 269 lung resections that met inclusion criteria. There were 135 men (50.2%) and 134 (49.8%) women with a mean age of 61.35 years, as is shown in <xref ref-type="table" rid="table1">Table 1</xref>.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Indications for pulmonary resection of 269 consecutive pulmonary resections, October 1<sup>st</sup> 2015 to June 30<sup>th</sup> 2016, by prolonged air leak status</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Primary diagnosis</th><th align="center" valign="middle" >Total n = 269 (No., %)</th><th align="center" valign="middle" >Control group air leak &lt; 5 days n = 238 (No., %)</th><th align="center" valign="middle" >Air leak ≥ 5 days n = 31 (No., %)</th><th align="center" valign="middle" >P-value*</th></tr></thead><tr><td align="center" valign="middle" >Lung cancer</td><td align="center" valign="middle" >165 (61.34)</td><td align="center" valign="middle" >141 (59.24)</td><td align="center" valign="middle" >24 (77.42)</td><td align="center" valign="middle"  rowspan="5"  >0.056</td></tr><tr><td align="center" valign="middle" >Lung metastases</td><td align="center" valign="middle" >31 (11.52)</td><td align="center" valign="middle" >31 (13.03)</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Recurrent pneumothorax</td><td align="center" valign="middle" >25 (9.29)</td><td align="center" valign="middle" >22 (9.24)</td><td align="center" valign="middle" >3 (9.68)</td></tr><tr><td align="center" valign="middle" >ILD</td><td align="center" valign="middle" >18 (6.69)</td><td align="center" valign="middle" >18 (7.56)</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Other (Benign lung lesions, infection)</td><td align="center" valign="middle" >30 (11.15)</td><td align="center" valign="middle" >26 (10.92)</td><td align="center" valign="middle" >4 (12.90)</td></tr></tbody></table></table-wrap><p>*Chi square test of association for categorical variables; *Two tail T-test of association for continuous variables.</p><p>PAL occurred in 31 patients (11.52%) and was most frequently observed in patients undergoing resection for primary lung cancer, followed by other causes and pneumothorax, as is shown in <xref ref-type="table" rid="table2">Table 2</xref>.</p><p>Patients with a normal BMI were more likely to have PAL compared to those with an overweight BMI (P = 0.007) on univariate analysis. For those with PAL there was a trend for increased age (P = 0.132). The proportion of PAL was highest in the 70 - 79 years age group (n = 12), but this did not reach statistical significance (P = 0.32). There is a trend for association of PAL with age ≥ 70 years (P = 0.105). Non-significant patient characteristics include mean age (P = 0.13), sex (P = 0.83), FEV1% predicted (P = 0.89), FEV1/FVC% (P = 0.38), DLCO% (P = 0.38).</p></sec><sec id="s3_2"><title>3.2. Validated Scoring Methods</title><p>When ECOG status is grouped into two categories: 0 - 1 and ≥2, there is very weak evidence of association of ECOG ≥ 2 with PAL (P = 0.099). Statistically insignificant validated scores include mean CCI (P = 0.38) and MRC dyspnea score (P = 0.55), as is shown in <xref ref-type="table" rid="table3">Table 3</xref>.</p></sec><sec id="s3_3"><title>3.3. Current Habits and Charlson Comorbidities</title><p>Cerebrovascular disease was found to be associated with PAL (P = 0.030) and there was a trend for association of uncomplicated diabetes with PAL (P = 0.145). All remaining comorbidities were not found to be significantly associated with PAL, as is shown in <xref ref-type="table" rid="table4">Table 4</xref>.</p></sec><sec id="s3_4"><title>3.4. Length of Stay and Readmission Outcomes</title><p>LOS was significantly longer for patients in the air leak group with a mean length of stay of 12.61 days compared to 4.95 days in the control group (P &lt; 0.001). PAL was not significantly associated with increased readmission rates. Readmission at 30 days was 3.2% (n = 1) in the PAL group and 0.42% (n = 1) in the control group (P = 0.22). Readmission at 90 days was 3.2% (n = 1) in the PAL group and 2.1% (n = 5) in the control group (P = 0.5). Frequency of readmission at 30 and 90 days was small and similar between groups. There were 2 deaths in the study, both in the control group, and due to</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Univariate analysis of patient characteristics for 269 consecutive pulmonary resections, October 1<sup>st</sup> 2015 to June 30<sup>th</sup> 2016, by prolonged air leak status</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variable</th><th align="center" valign="middle" >Total (No., %)</th><th align="center" valign="middle" >Control group air leak &lt; 5 days (No., %)</th><th align="center" valign="middle" >Air leak ≥ 5 days (No., %)</th><th align="center" valign="middle" >P-value*</th></tr></thead><tr><td align="center" valign="middle" >All pulmonary resections</td><td align="center" valign="middle" >269 (100)</td><td align="center" valign="middle" >238 (88.48)</td><td align="center" valign="middle" >31 (11.52)</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle"  colspan="5"  >Age</td></tr><tr><td align="center" valign="middle" >Age: Mean (SD)</td><td align="center" valign="middle" >61.35 (15.8, 59.5 - 63.3)</td><td align="center" valign="middle" >60.83 (16.1)</td><td align="center" valign="middle" >65.39 (12.49)</td><td align="center" valign="middle" >0.132</td></tr><tr><td align="center" valign="middle" >Age category (years):</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;50 51 - 59 60 - 69 70 - 79 &gt;80</td><td align="center" valign="middle" >43 (15.99) 59 (21.93) 80 (29.74) 65 (24.16) 22 (8.18)</td><td align="center" valign="middle" >39 (16.39) 52 (21.85) 74 (31.09) 53 (22.27) 20 (8.40)</td><td align="center" valign="middle" >4 (12.90) 7 (22.58) 6 (19.35) 12 (38.71) 2 (6.45)</td><td align="center" valign="middle" >0.322</td></tr><tr><td align="center" valign="middle" >Age ≥ 70 years</td><td align="center" valign="middle" >87 (32.34)</td><td align="center" valign="middle" >73 (30.67)</td><td align="center" valign="middle" >14 (45.16)</td><td align="center" valign="middle" >0.105</td></tr><tr><td align="center" valign="middle" >Sex:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Male Female</td><td align="center" valign="middle" >135 (50.19) 134 (49.81)</td><td align="center" valign="middle" >120 (50.42) 118 (49.58)</td><td align="center" valign="middle" >15 (48.39) 16 (51.61)</td><td align="center" valign="middle" >0.831</td></tr><tr><td align="center" valign="middle"  colspan="5"  >BMI</td></tr><tr><td align="center" valign="middle" >BMI: (n = 243)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Mean (SD)</td><td align="center" valign="middle" >25.59 (5.86)</td><td align="center" valign="middle" >25.77 (6.05)</td><td align="center" valign="middle" >25.59 (3.95)</td><td align="center" valign="middle" >0.1733</td></tr><tr><td align="center" valign="middle" >BMI category: (n = 243)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Underweight (&lt;18.5) Normal (18.5 - 25) Overweight (&gt;25)</td><td align="center" valign="middle" >18 (7.41) 110 (45.27) 115 (47.33)</td><td align="center" valign="middle" >18 (8.41) 89 (41.59) 107 (50.00)</td><td align="center" valign="middle" >0 (0) 21 (72.41) 8 (27.59)</td><td align="center" valign="middle" >0.007 (Fisher exact)</td></tr><tr><td align="center" valign="middle"  colspan="5"  >Pulmonary function testing</td></tr><tr><td align="center" valign="middle" >FEV1%: (n = 210)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Mean (SD)</td><td align="center" valign="middle" >86.27 (8.46)</td><td align="center" valign="middle" >86.33 (18.50)</td><td align="center" valign="middle" >85.8 (18.56)</td><td align="center" valign="middle" >0.8923</td></tr><tr><td align="center" valign="middle" >FEV1 category (n = 210)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;60% 60% - 80% &gt;80%</td><td align="center" valign="middle" >15 (7.14) 66 (31.43) 129 (61.43)</td><td align="center" valign="middle" >12 (6.49) 60 (32.43) 113 (61.08)</td><td align="center" valign="middle" >3 (12.00) 6 (24.00) 16 (64.00)</td><td align="center" valign="middle" >0.480</td></tr><tr><td align="center" valign="middle" >FEV1 &lt; 80%</td><td align="center" valign="middle" >81 (38.57)</td><td align="center" valign="middle" >72 (38.92)</td><td align="center" valign="middle" >9 (36.00)</td><td align="center" valign="middle" >0.778</td></tr><tr><td align="center" valign="middle" >FEV1 &lt; 60%</td><td align="center" valign="middle" >15 (7.14)</td><td align="center" valign="middle" >12 (6.49)</td><td align="center" valign="middle" >3 (12.00)</td><td align="center" valign="middle" >0.397</td></tr><tr><td align="center" valign="middle" >FEV1/FVC% (n = 206)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Mean (SD)</td><td align="center" valign="middle" >72.80 (11.89)</td><td align="center" valign="middle" >73.08 (11.73)</td><td align="center" valign="middle" >70.90 (13.0)</td><td align="center" valign="middle" >0.3843</td></tr><tr><td align="center" valign="middle" >FEV1/FVC% category</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;60% 60% - 80% &gt;80%</td><td align="center" valign="middle" >23 (11.17) 130 (63.11) 53 (25.73)</td><td align="center" valign="middle" >20 (11.11) 112 (62.22) 48 (26.67)</td><td align="center" valign="middle" >3 (11.54) 18 (69.23) 5 (19.23)</td><td align="center" valign="middle" >0.716</td></tr><tr><td align="center" valign="middle" >DLCO% (n = 202)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Mean (SD)</td><td align="center" valign="middle" >76.05 (18.31)</td><td align="center" valign="middle" >76.45 (18.23)</td><td align="center" valign="middle" >72.91 (19.03)</td><td align="center" valign="middle" >0.3841</td></tr><tr><td align="center" valign="middle" >DLCO% category</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;60% 60% - 80% &gt;80%</td><td align="center" valign="middle" >36 (17.82) 79 (39.11) 79 (43.07)</td><td align="center" valign="middle" >30 (16.76) 69 (38.55) 80 (44.69)</td><td align="center" valign="middle" >6 (26.09) 10 (43.48) 7 (30.43)</td><td align="center" valign="middle" >0.353</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Validated scoring tools for study population of 269 consecutive pulmonary resections, October 1<sup>st</sup> 2015 to June 30<sup>th</sup> 2016, by prolonged air leak status</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variable</th><th align="center" valign="middle" >Total (No., %)</th><th align="center" valign="middle" >Control group air leak &lt; 5 days (No., %)</th><th align="center" valign="middle" >Air leak ≥ 5 days (No., %)</th><th align="center" valign="middle" >P-value*</th></tr></thead><tr><td align="center" valign="middle" >CC Index (n = 269)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Mean (SD)</td><td align="center" valign="middle" >1.6 (1.7)</td><td align="center" valign="middle" >1.6 (1.7)</td><td align="center" valign="middle" >1.5 (1.3)</td><td align="center" valign="middle" >0.3786</td></tr><tr><td align="center" valign="middle" >CC index category: (n = 269)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >0 1 - 2 3 - 4 ≥5</td><td align="center" valign="middle" >86 (31.97) 126 (46.84) 37 (13.75) 20 (7.43)</td><td align="center" valign="middle" >77 (2.35) 110 (46.22) 31 (13.03) 20 (8.40)</td><td align="center" valign="middle" >9 (29.03) 16 (51.61) 6 (19.35) 0</td><td align="center" valign="middle" >0.300</td></tr><tr><td align="center" valign="middle" >ECOG performance status (n = 266) category:</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >ECOG 0 ECOG 1 ECOG 2 ECOG 3</td><td align="center" valign="middle" >165 (62.03) 84 (31.58) 12 (4.51) 5 (1.88)</td><td align="center" valign="middle" >148 (62.71) 75 (31.78) 9 (3.81) 4 (1.69)</td><td align="center" valign="middle" >17 (56.67) 9 (30.0) 3 (10.0) 1 (1.88)</td><td align="center" valign="middle" >0.420</td></tr><tr><td align="center" valign="middle" >ECOG grouping: (n = 266)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >ECOG 0 - 1 ECOG ≥2</td><td align="center" valign="middle" >249 (93.61) 17 (6.39)</td><td align="center" valign="middle" >223 (94.49) 13 (5.51)</td><td align="center" valign="middle" >26 (86.67) 4 (13.33)</td><td align="center" valign="middle" >0.099</td></tr><tr><td align="center" valign="middle" >MRC dyspnea scores (n = 266)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >1 2 3 4</td><td align="center" valign="middle" >172 (64.66) 73 (27.44) 15 (5.64) 6 (2.26)</td><td align="center" valign="middle" >154 (65.25) 64 (27.12) 12 (5.08) 6 (2.54)</td><td align="center" valign="middle" >18 (60.00) 9 (30.00) 3 (10.00) 0</td><td align="center" valign="middle" >0.552</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Current habits and Charlston comorbidities for study population of 269 consecutive pulmonary resections, October 1<sup>st</sup> 2015 to June 30<sup>th</sup> 2016, by prolonged air leak status</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variable</th><th align="center" valign="middle" >Total (No., %)</th><th align="center" valign="middle" >Control group air leak &lt; 5 days n = 238 (No., %)</th><th align="center" valign="middle" >Air leak ≥ 5 days n = 31 (No., %)</th><th align="center" valign="middle" >P-value*</th></tr></thead><tr><td align="center" valign="middle"  colspan="5"  >Current habit</td></tr><tr><td align="center" valign="middle" >Smoker</td><td align="center" valign="middle" >32 (11.90)</td><td align="center" valign="middle" >27 (11.34)</td><td align="center" valign="middle" >5 (16.13)</td><td align="center" valign="middle" >0.389</td></tr><tr><td align="center" valign="middle" >Alcoholism</td><td align="center" valign="middle" >7 (2.60)</td><td align="center" valign="middle" >6 (2.52)</td><td align="center" valign="middle" >1 (3.23)</td><td align="center" valign="middle" >0.580</td></tr><tr><td align="center" valign="middle"  colspan="5"  >Comorbid disease</td></tr><tr><td align="center" valign="middle" >CAD</td><td align="center" valign="middle" >28 (10.41)</td><td align="center" valign="middle" >25 (10.50)</td><td align="center" valign="middle" >3 (9.68)</td><td align="center" valign="middle" >0.887</td></tr><tr><td align="center" valign="middle" >CHF</td><td align="center" valign="middle" >7 (2.60)</td><td align="center" valign="middle" >2 (6.45)</td><td align="center" valign="middle" >5 (2.10)</td><td align="center" valign="middle" >0.187</td></tr><tr><td align="center" valign="middle" >PVD</td><td align="center" valign="middle" >11 (4.09)</td><td align="center" valign="middle" >2 (6.45)</td><td align="center" valign="middle" >9 (3.78)</td><td align="center" valign="middle" >0.369</td></tr><tr><td align="center" valign="middle" >Cerebrovascular disease</td><td align="center" valign="middle" >24 (8.92)</td><td align="center" valign="middle" >18 (7.56)</td><td align="center" valign="middle" >6 (19.35)</td><td align="center" valign="middle" >0.030</td></tr><tr><td align="center" valign="middle" >Chronic lung disease</td><td align="center" valign="middle" >96 (35.69)</td><td align="center" valign="middle" >13 (41.94)</td><td align="center" valign="middle" >83 (34.87)</td><td align="center" valign="middle" >0.434</td></tr><tr><td align="center" valign="middle" >Chronic cognitive deficit</td><td align="center" valign="middle" >1 (0.37)</td><td align="center" valign="middle" >1 (0.42)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.718</td></tr><tr><td align="center" valign="middle" >Connective tissue disease</td><td align="center" valign="middle" >15 (5.58)</td><td align="center" valign="middle" >12 (5.04)</td><td align="center" valign="middle" >3 (9.68)</td><td align="center" valign="middle" >0.393</td></tr><tr><td align="center" valign="middle" >PUD</td><td align="center" valign="middle" >6 (2.23)</td><td align="center" valign="middle" >6 (2.52)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.371</td></tr><tr><td align="center" valign="middle" >DM uncomplicated</td><td align="center" valign="middle" >32 (11.90)</td><td align="center" valign="middle" >31 (13.03)</td><td align="center" valign="middle" >1 (3.23)</td><td align="center" valign="middle" >0.145</td></tr><tr><td align="center" valign="middle" >DM complicated</td><td align="center" valign="middle" >3 (1.12)</td><td align="center" valign="middle" >3 (1.26)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.530</td></tr><tr><td align="center" valign="middle" >CKD moderate to severe</td><td align="center" valign="middle" >6 (2.23)</td><td align="center" valign="middle" >5 (2.10)</td><td align="center" valign="middle" >1 (3.23)</td><td align="center" valign="middle" >0.524</td></tr><tr><td align="center" valign="middle" >Leukemia</td><td align="center" valign="middle" >3 (1.12)</td><td align="center" valign="middle" >3 (1.26)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.530</td></tr><tr><td align="center" valign="middle" >Lymphoma</td><td align="center" valign="middle" >5 (1.86)</td><td align="center" valign="middle" >4 (1.68)</td><td align="center" valign="middle" >1 (3.23)</td><td align="center" valign="middle" >0.460</td></tr><tr><td align="center" valign="middle" >Solid tumour no mets</td><td align="center" valign="middle" >45</td><td align="center" valign="middle" >39 (16.39)</td><td align="center" valign="middle" >6 (19.35)</td><td align="center" valign="middle" >0.617</td></tr><tr><td align="center" valign="middle" >Solid tumour with mets</td><td align="center" valign="middle" >11 (4.09)</td><td align="center" valign="middle" >11 (4.62)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.622</td></tr><tr><td align="center" valign="middle" >Liver disease mild</td><td align="center" valign="middle" >7 (2.60)</td><td align="center" valign="middle" >7 (2.94)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.333</td></tr><tr><td align="center" valign="middle" >HIV/AIDS</td><td align="center" valign="middle" >1 (0.37)</td><td align="center" valign="middle" >1 (0.42)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.718</td></tr></tbody></table></table-wrap><p>cardiac arrest (n = 1) and acute respiratory distress syndrome (ARDS) (n = 1), as is shown in <xref ref-type="table" rid="table5">Table 5</xref>.</p></sec><sec id="s3_5"><title>3.5. Surgical Factors</title><p>The majority of surgeries (93.3%) were performed using video-assisted thoracoscopic surgery (VATS). Surgical factors that are statistically significant risk factor for PAL include VATS that involved an unplanned conversion to thoracotomy (P = 0.011) and RUL lobectomy (P = 0.001). Any upper lobectomy, defined as right upper lobectomy, left upper lobectomy, or left apical trisegmentectomy, was significantly associated with PAL (P = 0.014), as well as any upper lobectomy or bilobectomy (P = 0.012). Also significantly associated with PAL was the presence of adhesions (P &lt; 0.001), as is shown in <xref ref-type="table" rid="table6">Table 6</xref>.</p></sec><sec id="s3_6"><title>3.6. Multivariate Analysis</title><p>The results following multivariate regression analysis are shown in <xref ref-type="table" rid="table7">Table 7</xref> and <xref ref-type="table" rid="table8">Table 8</xref>. Significant predictors of PAL following multivariate regression include unplanned conversion from VATS to thoracotomy (P = 0.023), right upper lobectomy (P = 0.001), and normal BMI compared to an overweight BMI (P = 0.009).</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>The aim of this retrospective cohort study was to investigate the incidence of PAL following pulmonary resection and the most common risk factors for PAL in this group of patients. We defined a prolonged air leak as an air leak lasting 5 or more days post- operatively. In previous studies, PAL has been found to occur in up to 26% of patients following lobectomy and lesser pulmonary resections [<xref ref-type="bibr" rid="scirp.71857-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref8">8</xref>] and is associated with increased postoperative morbidity through increased rates of pulmonary and pleural complications such as empyema, pneumonia, and atelectasis [<xref ref-type="bibr" rid="scirp.71857-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref9">9</xref>] . In this study the incidence of prolonged air leak was 11.52% which is similar to the incidence found in previous studies.</p><p>Previous studies have found that the impact of PAL on the healthcare system is significant as it prolongs hospital stay by 4 to 13 days [<xref ref-type="bibr" rid="scirp.71857-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref16">16</xref>] and as a result increases</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Length of stay, mortality, and readmission univariable analysis for study population of 269 consecutive pulmonary resections, October 1<sup>st</sup> 2015 to June 30<sup>th</sup> 2016, by prolonged air leak status</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variable</th><th align="center" valign="middle" >Total (No., %)</th><th align="center" valign="middle" >Control group air leak &lt; 5 days n = 238 (No., %)</th><th align="center" valign="middle" >Air leak ≥ 5 days n = 31 (No., %)</th><th align="center" valign="middle" >P-value*</th></tr></thead><tr><td align="center" valign="middle" >LOS (days) n = 269 Mean (SD)</td><td align="center" valign="middle" >5.83 (5.47)</td><td align="center" valign="middle" >4.95 (4.65)</td><td align="center" valign="middle" >12.61 (6.54)</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >All cause 30 day mortality</td><td align="center" valign="middle" >2 (0.74)</td><td align="center" valign="middle" >2 (0.84)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.608</td></tr><tr><td align="center" valign="middle" >30 day readmit</td><td align="center" valign="middle" >2 (0.74)</td><td align="center" valign="middle" >1 (0.42)</td><td align="center" valign="middle" >1 (3.23)</td><td align="center" valign="middle" >0.218</td></tr><tr><td align="center" valign="middle" >90 day readmit</td><td align="center" valign="middle" >6 (2.23)</td><td align="center" valign="middle" >5 (2.10)</td><td align="center" valign="middle" >1 (3.23)</td><td align="center" valign="middle" >0.524</td></tr></tbody></table></table-wrap><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Surgical risk factors for study population of 269 consecutive pulmonary resections, October 1<sup>st</sup> 2015 to June 30<sup>th</sup> 2016, by prolonged air leak status</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variable</th><th align="center" valign="middle" >Total n = 269 (No., %)</th><th align="center" valign="middle" >Control group air leak &lt; 5 days n = 238 (No., %)</th><th align="center" valign="middle" >Air leak ≥ 5 days n = 31 (No., %)</th><th align="center" valign="middle" >P-value*</th></tr></thead><tr><td align="center" valign="middle" >Planned incision</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >VATS Thoracotomy Sternotomy</td><td align="center" valign="middle" >251 (93.31) 16 (5.95) 2 (0.74)</td><td align="center" valign="middle" >220 (92.44) 16 (6.72) 2 ()</td><td align="center" valign="middle" >31 (100) 0 0</td><td align="center" valign="middle" >0.285</td></tr><tr><td align="center" valign="middle" >Unplanned conversion VATS to thoracotomy</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes No</td><td align="center" valign="middle" >248 (92.19) 21 (7.81)</td><td align="center" valign="middle" >15 (6.30) 223 (93.70)</td><td align="center" valign="middle" >6 (19.35) 25 (80.65)</td><td align="center" valign="middle" >0.011</td></tr><tr><td align="center" valign="middle" >Lobectomy</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes No</td><td align="center" valign="middle" >134 (49.81) 135 (50.19)</td><td align="center" valign="middle" >115 (48.32) 123 (51.68)</td><td align="center" valign="middle" >19 (61.29) 12 (38.71)</td><td align="center" valign="middle" >0.174</td></tr><tr><td align="center" valign="middle" >Lobectomy location</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >RUL RML RLL LUL LLL</td><td align="center" valign="middle" >42 (15.61) 10 (3.72) 27 (10.04) 33 (12.27) 21 (7.81)</td><td align="center" valign="middle" >31 (13.03) 10 (4.20) 23 (9.66) 30 (12.61) 20 (8.40)</td><td align="center" valign="middle" >11 (35.48) 0 4 (12.90) 3 (9.68) 1 (3.23)</td><td align="center" valign="middle" >0.001 0.611 0.530 0.778 0.485</td></tr><tr><td align="center" valign="middle" >Bilobectomy</td><td align="center" valign="middle" >9 (3.35)</td><td align="center" valign="middle" >8 (3.36)</td><td align="center" valign="middle" >1 (3.23)</td><td align="center" valign="middle" >0.969</td></tr><tr><td align="center" valign="middle" >Location bilobectomy</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >RUL/RML RML/RLL</td><td align="center" valign="middle" >4 (44.44) 5 (55.56)</td><td align="center" valign="middle" >3 (37.50) 5 (62.50)</td><td align="center" valign="middle" >1 (100) 0</td><td align="center" valign="middle" >0.444</td></tr><tr><td align="center" valign="middle" >Segmentectomy</td><td align="center" valign="middle" >17 (6.32)</td><td align="center" valign="middle" >15 (6.30)</td><td align="center" valign="middle" >2 (6.45)</td><td align="center" valign="middle" >0.974</td></tr><tr><td align="center" valign="middle" >Location segmentectomy</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >LUL apical trisegment LUL lingula LLL sup seg RLL sup seg</td><td align="center" valign="middle" >9 (52.94) 2 (11.76) 2 (11.76) 4 (23.53)</td><td align="center" valign="middle" >7 (46.67) 2 (13.33) 2 (13.33) 4 (26.67)</td><td align="center" valign="middle" >2 (100) 0 0 0</td><td align="center" valign="middle" >0.569</td></tr><tr><td align="center" valign="middle" >Any upper lobectomy</td><td align="center" valign="middle" >85 (31.60)</td><td align="center" valign="middle" >69 (28.99)</td><td align="center" valign="middle" >16 (51.61)</td><td align="center" valign="middle" >0.014</td></tr><tr><td align="center" valign="middle" >Any upper lobectomy or bilobectomy</td><td align="center" valign="middle" >93 (4.57)</td><td align="center" valign="middle" >76 (31.93)</td><td align="center" valign="middle" >17 (54.84)</td><td align="center" valign="middle" >0.012</td></tr><tr><td align="center" valign="middle" >Wedge resection</td><td align="center" valign="middle" >115 (42.75)</td><td align="center" valign="middle" >103 (43.28)</td><td align="center" valign="middle" >12 (38.71)</td><td align="center" valign="middle" >0.629</td></tr><tr><td align="center" valign="middle" >Adhesions &gt; 30% pleural surface</td><td align="center" valign="middle" >56 (20.97)</td><td align="center" valign="middle" >40 (16.88)</td><td align="center" valign="middle" >16 (53.33)</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Incomplete major fissure</td><td align="center" valign="middle" >140 (92.72)</td><td align="center" valign="middle" >119 (91.54)</td><td align="center" valign="middle" >21 (100)</td><td align="center" valign="middle" >0.384</td></tr><tr><td align="center" valign="middle" >Fissure division</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Stapler Cautery Combination</td><td align="center" valign="middle" >103 (72.54) 6 (4.23) 33 (23.24)</td><td align="center" valign="middle" >86 (71.07) 6 (4.96) 29 (23.97)</td><td align="center" valign="middle" >17 (80.95) 0 4 (10.05)</td><td align="center" valign="middle" >0.744</td></tr><tr><td align="center" valign="middle" >Intraoperative transfusion</td><td align="center" valign="middle" >3 (1.12)</td><td align="center" valign="middle" >3 (1.26)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.530</td></tr></tbody></table></table-wrap><table-wrap id="table7" ><label><xref ref-type="table" rid="table7">Table 7</xref></label><caption><title> Logistic regression and multivariable regression analysis of surigical factors for study population of 269 consecutive pulmonary resections, October 1<sup>st</sup> 2015 to June 30<sup>th</sup> 2016</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variable</th><th align="center" valign="middle"  colspan="2"  >Univariable analysis</th><th align="center" valign="middle"  colspan="2"  >Multivariable analysis</th></tr></thead><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Odds ratio (95%CI)</td><td align="center" valign="middle" >P-value*</td><td align="center" valign="middle" >Odds ratio (95%CI)</td><td align="center" valign="middle" >P-value*</td></tr><tr><td align="center" valign="middle" >Unplanned conversion VATS to thoracotomy</td><td align="center" valign="middle" >3.57 (1.3 - 10.0)</td><td align="center" valign="middle" >0.016</td><td align="center" valign="middle" >3.37 (1.2 - 9.6)</td><td align="center" valign="middle" >0.023</td></tr><tr><td align="center" valign="middle" >Lobectomy</td><td align="center" valign="middle" >0.99 (0.8 - 1.3)</td><td align="center" valign="middle" >0.951</td><td align="center" valign="middle" >1.78 (0.8 - 4.0)</td><td align="center" valign="middle" >0.170</td></tr><tr><td align="center" valign="middle" >Lobectomy location</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >RUL RML RLL LUL LLL</td><td align="center" valign="middle" >3.67 (1.6 - 8.4) - 1.38 (0.4 - 4.3) 0.74 (0.2 - 2.6) 0.36 (0.04 - 2.8)</td><td align="center" valign="middle" >0.002 - 0.574 0.641 0.332</td><td align="center" valign="middle" >4.16 (1.7 - 10) - 1.27 (0.4 - 4.1) 0.72 (0.2 - 2.6) 0.37 (0.04 - 2.9)</td><td align="center" valign="middle" >0.001 - 0.692 0.607 0.349</td></tr><tr><td align="center" valign="middle" >Bilobectomy</td><td align="center" valign="middle" >0.96 (0.12 - 7.9)</td><td align="center" valign="middle" >0.969</td><td align="center" valign="middle" >0.88 (0.1 - 7.4)</td><td align="center" valign="middle" >0.904</td></tr><tr><td align="center" valign="middle" >Segmentectomy</td><td align="center" valign="middle" >1.02 (0.2 - 4.7)</td><td align="center" valign="middle" >0.974</td><td align="center" valign="middle" >1.04 (0.2 - 4.8)</td><td align="center" valign="middle" >0.962</td></tr><tr><td align="center" valign="middle" >Wedge resection</td><td align="center" valign="middle" >0.82 (0.4 - 1.8)</td><td align="center" valign="middle" >0.629</td><td align="center" valign="middle" >0.81 (0.4 - 1.9)</td><td align="center" valign="middle" >0.632</td></tr><tr><td align="center" valign="middle" >Adhesions &gt;30% pleural surface</td><td align="center" valign="middle" >1.56 (0.9 - 2.6)</td><td align="center" valign="middle" >0.092</td><td align="center" valign="middle" >1.53 (0.91 - 2.6)</td><td align="center" valign="middle" >0.106</td></tr><tr><td align="center" valign="middle" >Fissure division</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Stapler Cautery Combination</td><td align="center" valign="middle" >- 1.43 (0.4 - 4.6) -</td><td align="center" valign="middle" >- 0.546 -</td><td align="center" valign="middle" >- 1.53 (0.5 - 5.1) -</td><td align="center" valign="middle" >- 0.487 -</td></tr></tbody></table></table-wrap><p>health-care costs [<xref ref-type="bibr" rid="scirp.71857-ref17">17</xref>] . The mean LOS for patients with PAL in our study was significantly longer at 12.6 days compared to 5.0 days for patients in the control group (P &lt; 0.0001). There was no association found between PAL and readmission rates at 30 and 90 days, or increased mortality.</p><p>Preoperative patient characteristics, validated scoring methods, and surgical factors were analyzed as possible risk factors. Normal BMI, compared to an overweight BMI, was a significant predictor of PAL. A relatively lower BMI has been found to be a risk factor in other studies [<xref ref-type="bibr" rid="scirp.71857-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref14">14</xref>] . Brunelli et al. [<xref ref-type="bibr" rid="scirp.71857-ref13">13</xref>] developed a scoring system based assigning points based on individual risk factors, with a maximum score of 5.5, and includes 2 points for BMI &lt; 25.5. From the total score they assigned four risk categories which demonstrated increasing PAL incidence in their validation set. Rivera et al. [<xref ref-type="bibr" rid="scirp.71857-ref14">14</xref>] developed an Index of PAL (IPAL), in which BMI &lt; 24 increases IPAL, which is associated with increased risk of PAL. Patients with an overweight BMI have increased intra-abdominal pressure which forces the diaphragm cephalad helping to reduce the residual space following resection. There was a trend for age &gt; 70 to be associated with PAL which may be due to a more fragile lung parenchyma and reduced healing capacity in this population. There was also a trend for association of FEV1 &gt; 80% and DLCO &gt; 80% with decreased odds of PAL on multivariate analysis. This aligns with previous studies which have consistently found reduced pulmonary function due to</p><table-wrap-group id="8"><label><xref ref-type="table" rid="table8">Table 8</xref></label><caption><title> Logistic regression and multivariable regression analysis of patient characteristics for study population of 269 consecutive pulmonary resections, October 1<sup>st</sup> 2015 to June 30<sup>th</sup> 2016</title></caption><table-wrap id="8_1"><table><tbody><thead><tr><th align="center" valign="middle" >Variable</th><th align="center" valign="middle"  colspan="2"  >Univariable analysis</th><th align="center" valign="middle"  colspan="2"  >Multivariable analysis</th></tr></thead><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Odds ratio (95%CI)</td><td align="center" valign="middle" >P-value*</td><td align="center" valign="middle" >Odds ratio (95%CI)</td><td align="center" valign="middle" >P-value*</td></tr><tr><td align="center" valign="middle"  colspan="5"  >Age (years) (n = 269)</td></tr><tr><td align="center" valign="middle" >41 - 50</td><td align="center" valign="middle" >1.00 (Reference)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >1.00 (Reference)</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >51 - 60</td><td align="center" valign="middle" >1.31 (0.4 - 4.8)</td><td align="center" valign="middle" >0.681</td><td align="center" valign="middle" >1.22 (0.3 - 4.5)</td><td align="center" valign="middle" >0.766</td></tr><tr><td align="center" valign="middle" >61 - 70</td><td align="center" valign="middle" >0.79 (0.2 - 3.0)</td><td align="center" valign="middle" >0.728</td><td align="center" valign="middle" >0.74 (0.2 - 2.8)</td><td align="center" valign="middle" >0.662</td></tr><tr><td align="center" valign="middle" >71 - 80</td><td align="center" valign="middle" >2.21 (0.7 - 7.4)</td><td align="center" valign="middle" >0.198</td><td align="center" valign="middle" >1.92 (0.6 - 6.6)</td><td align="center" valign="middle" >0.300</td></tr><tr><td align="center" valign="middle" >&gt;80</td><td align="center" valign="middle" >0.98 (0.2 - 5.8)</td><td align="center" valign="middle" >0.978</td><td align="center" valign="middle" >0.89 (0.1 - 5.4)</td><td align="center" valign="middle" >0.899</td></tr><tr><td align="center" valign="middle" >Age &gt;70 years</td><td align="center" valign="middle" >1.86 (0.9 - 4.0)</td><td align="center" valign="middle" >0.109</td><td align="center" valign="middle" >1.71 (0.8 - 3.7)</td><td align="center" valign="middle" >0.178</td></tr><tr><td align="center" valign="middle"  colspan="5"  >Sex (n = 269)</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >1.00 (Reference)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >1.00 (Reference)</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >1.08 (0.5 - 2.3)</td><td align="center" valign="middle" >0.831</td><td align="center" valign="middle" >1.30 (0.6 - 2.9)</td><td align="center" valign="middle" >0.509</td></tr><tr><td align="center" valign="middle"  colspan="5"  >Charlson co-morbidity score (n = 269)</td></tr><tr><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1.00 (Reference)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >1.00 (Reference)</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >1 - 2</td><td align="center" valign="middle" >1.24 (0.5 - 2.9)</td><td align="center" valign="middle" >0.621</td><td align="center" valign="middle" >1.05 (0.4 - 2.6)</td><td align="center" valign="middle" >0.922</td></tr><tr><td align="center" valign="middle" >3 - 4</td><td align="center" valign="middle" >1.65 (0.5 - 5.0)</td><td align="center" valign="middle" >0.375</td><td align="center" valign="middle" >1.26 (0.4 - 4.2)</td><td align="center" valign="middle" >0.705</td></tr><tr><td align="center" valign="middle" >≥ 5</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle"  colspan="5"  >BMI category: (n = 243)</td></tr><tr><td align="center" valign="middle" >Underweight (&lt;18.5)</td><td align="center" valign="middle" >1.00 (Reference)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >1.00 (Reference)</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Normal (18.5 - 25)</td><td align="center" valign="middle" >3.16 (1.3 - 7.5)</td><td align="center" valign="middle" >0.009</td><td align="center" valign="middle" >3.28 (1.3 - 8.0)</td><td align="center" valign="middle" >0.009</td></tr><tr><td align="center" valign="middle" >Overweight (&gt;25)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle"  colspan="5"  >FEV1 category (n = 210)</td></tr><tr><td align="center" valign="middle" >&lt;60%</td><td align="center" valign="middle" >1.00 (Reference)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >1.00 (Reference)</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >60 - 80%</td><td align="center" valign="middle" >0.40 (0.1 - 1.8)</td><td align="center" valign="middle" >0.237</td><td align="center" valign="middle" >0.34</td><td align="center" valign="middle" >0.176</td></tr><tr><td align="center" valign="middle" >&gt;80%</td><td align="center" valign="middle" >0.57 (0.1 - 2.2)</td><td align="center" valign="middle" >0.416</td><td align="center" valign="middle" >0.38</td><td align="center" valign="middle" >0.210</td></tr><tr><td align="center" valign="middle"  colspan="5"  >FVC/FEV1% category (n = 206)</td></tr><tr><td align="center" valign="middle" >&lt;60%</td><td align="center" valign="middle" >1.00 (Reference)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >1.00 (Reference)</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >60 - 80%</td><td align="center" valign="middle" >1.07 (0.3 - 4.0)</td><td align="center" valign="middle" >0.918</td><td align="center" valign="middle" >0.79 (0.2 - 3.1)</td><td align="center" valign="middle" >0.739</td></tr><tr><td align="center" valign="middle" >&gt;80%</td><td align="center" valign="middle" >0.69 (0.2 - 3.2)</td><td align="center" valign="middle" >0.639</td><td align="center" valign="middle" >0.48 (0.1 - 2.4)</td><td align="center" valign="middle" >0.377</td></tr><tr><td align="center" valign="middle"  colspan="5"  >DLCO% category (n = 202)</td></tr><tr><td align="center" valign="middle" >&lt;60%</td><td align="center" valign="middle" >1.00 (Reference)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >1.00 (Reference)</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >60 - 80%</td><td align="center" valign="middle" >0.72 (0.2 - 2.2)</td><td align="center" valign="middle" >0.566</td><td align="center" valign="middle" >0.65 (0.2 - 2.0)</td><td align="center" valign="middle" >0.452</td></tr><tr><td align="center" valign="middle" >&gt;80%</td><td align="center" valign="middle" >0.44 (0.1 - 1.4)</td><td align="center" valign="middle" >0.166</td><td align="center" valign="middle" >0.35 (0.1 - 1.3)</td><td align="center" valign="middle" >0.107</td></tr></tbody></table></table-wrap><table-wrap id="8_2"><table><tbody><thead><tr><th align="center" valign="middle"  colspan="5"  >ECOG performance status category: (n = 266)</th></tr></thead><tr><td align="center" valign="middle" >ECOG 0</td><td align="center" valign="middle" >1.00 (Reference)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >1.00 (Reference)</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >ECOG 1</td><td align="center" valign="middle" >1.04 (0.4 - 2.5)</td><td align="center" valign="middle" >0.920</td><td align="center" valign="middle" >1.18 (0.5 - 2.9)</td><td align="center" valign="middle" >0.725</td></tr><tr><td align="center" valign="middle" >ECOG 2</td><td align="center" valign="middle" >2.90 (0.7 - 11.8)</td><td align="center" valign="middle" >0.136</td><td align="center" valign="middle" >3.59 (0.8 - 16.0)</td><td align="center" valign="middle" >0.094</td></tr><tr><td align="center" valign="middle" >ECOG 3</td><td align="center" valign="middle" >2.18 (0.2 - 20.6)</td><td align="center" valign="middle" >0.498</td><td align="center" valign="middle" >2.51 (0.3 - 24.3)</td><td align="center" valign="middle" >0.428</td></tr><tr><td align="center" valign="middle"  colspan="5"  >ECOG grouping: (n = 266)</td></tr><tr><td align="center" valign="middle" >ECOG 0-1</td><td align="center" valign="middle" >1.00 (Reference)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >1.00 (Reference)</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >ECOG ≥2</td><td align="center" valign="middle" >2.64 (0.8 - 8.7)</td><td align="center" valign="middle" >0.111</td><td align="center" valign="middle" >3.00 (0.9 - 10.4)</td><td align="center" valign="middle" >0.083</td></tr><tr><td align="center" valign="middle"  colspan="5"  >MRC dyspnea scores (n = 266)</td></tr><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.00 (Reference)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >1.00 (Reference)</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.20</td><td align="center" valign="middle" >0.670</td><td align="center" valign="middle" >0.66 (0.2 - 2.3)</td><td align="center" valign="middle" >0.512</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >2.14</td><td align="center" valign="middle" >0.272</td><td align="center" valign="middle" >1.01 (0.2 - 6.0)</td><td align="center" valign="middle" >0.993</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle"  colspan="5"  >MRC dyspnea score grouping (n = 266)</td></tr><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.00 (Reference)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >1.00 (Reference)</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >≥2</td><td align="center" valign="middle" >1.25 (0.6 - 2.7)</td><td align="center" valign="middle" >0.571</td><td align="center" valign="middle" >0.81 (0.2 - 2.6)</td><td align="center" valign="middle" >0.729</td></tr></tbody></table></table-wrap></table-wrap-group><p>chronic obstructive pulmonary disease as a risk factor [<xref ref-type="bibr" rid="scirp.71857-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref12">12</xref>] . There was also a trend for risk of air leak to differ based on primary diagnosis, however, due to the small sample size, we were unable to perform multivariate analysis.</p><p>The CCI was developed in 1987 by Charlson and colleagues in a cohort study of 559 medical patients as a weighted sum of patient comorbid conditions [<xref ref-type="bibr" rid="scirp.71857-ref20">20</xref>] . It was subsequently tested in a population of patients undergoing treatment for breast cancer, and when patients were grouped into CCI categories of 0, 1 - 2, 3 - 4, and ≥5, there was a stepwise increase in mortality with increasing CCI. Birim et al. [<xref ref-type="bibr" rid="scirp.71857-ref21">21</xref>] investigated using the CCI to predict surgical risk in patients operated on for non-small cell lung cancer, and found that the CCI was a strong predictor of major complications, but not minor complications which included air leak &gt;5 days [<xref ref-type="bibr" rid="scirp.71857-ref21">21</xref>] . CCI grouped into the categories mentioned above was not found to be a predictor of PAL, however from univariate analysis of the individual Charlson comorbidities there was an association between cerebrovascular disease (CVD) and PAL, which may be due to smoking as a risk factor for CVD. For this study we investigated whether current smoking was a risk factor for PAL, and it is a limitation of this study that we did not take into consideration pack- year smoking history. There was also a trend for association of uncomplicated diabetes mellitus with PAL which may be due to reduced healing capacity in diabetic patients. There is weak evidence of an association of ECOG ≥ 2 with PAL and MRC dyspnea score did not have a significant association with PAL.</p><p>Surgical factors that had a statistically significant association with PAL include an unplanned conversion from VATS to thoracotomy, presence of adhesions, and right upper lobectomy. Conversion from VATS to thoracotomy occurred with operations in which it was difficult to access and resect necessary structures which resulted in increased lung manipulation. Some of the conversions from VATS to thoracotomy were performed due to the presence of dense adhesions. Previous studies have found adhesions to be a risk factor for PAL [<xref ref-type="bibr" rid="scirp.71857-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.71857-ref12">12</xref>] as their presence may cause tears in the lung parenchyma with manipulation of the lung, contributing to PAL. Right upper lobectomy involves both the major and minor fissures. There was a trend for association of lobectomy and upper lobectomy with PAL. Lobectomies involve resection of more lung parenchyma compared to sublobar resections, and combined with the effects of gravity, a larger residual apical space may prevent visceral and parietal pleural apposition for upper lobectomies.</p><p>Limitations include that this a single-centre study with a small sample size. Furthermore, as a retrospective observational study, the patient data collected and operation reports were not intended to be used for this purpose, and therefore there is bias introduced through the interpretation of these data sources.</p></sec><sec id="s5"><title>5. Conclusion</title><p>In conclusion, unplanned conversion, adhesions, and right upper lobectomy were the most significant surgical factors associated with PAL in our study. We observed several trends consistent with previously described predictors in the literature; however, our study was limited by small sample size.</p></sec><sec id="s6"><title>Cite this paper</title><p>Drewbrook, C., Das, S., Mousadoust, D., Nasir, B., Yee, J. and McGuire, A. (2016) Incidence Risk and Independent Predictors of Prolonged Air Leak in 269 Consecutive Pulmonary Resection Patients over Nine Months: A Single- Center Retrospective Cohort Study. Open Journal of Thoracic Surgery, 6, 33-46. http://dx.doi.org/10.4236/ojts.2016.64006</p></sec></body><back><ref-list><title>References</title><ref id="scirp.71857-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Singhal, S., Ferraris, V.A., Bridges, C.R., Clough, E.R., Mitchell, J.D., Fernando, H.C., et al. (2010) Management of Alveolar Air Leaks after Pulmonary Resection. Annals of Thoracic Surgery, 89, 1327-1335. http://dx.doi.org/10.1016/j.athoracsur.2009.09.020</mixed-citation></ref><ref id="scirp.71857-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Mueller, M.R. and Marzluf, B.A. (2014) The Anticipation and Management of Air Leaks and Residual Spaces Post Lung Resection. Journal of Thoracic Disease, 6, 271-284.</mixed-citation></ref><ref id="scirp.71857-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Burt, B.M. and Shrager, J.B. (2014) Prevention and Management of Postoperative Air Leaks. Annals of Cardiothoracic Surgery, 3, 216-218.</mixed-citation></ref><ref id="scirp.71857-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Stephan, F., Boucheseiche, S., Hollande, J., Flahault, A., Cheffi, A., Bazelly, B. and Bonnet, F. (2000) Pulmonary Complications Following Lung Resection. Chest, 118, 1263-1270. 
http://dx.doi.org/10.1378/chest.118.5.1263</mixed-citation></ref><ref id="scirp.71857-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Brunelli, A., Montebverde, M., Borrin, A., Salati, M., Marasco, R. and Fianchini, A. (2004) Predictors of Prolonged Air Leak after Pulmonary Lobectomy. Annals of Thoracic Surgery, 77, 1205-1210. http://dx.doi.org/10.1016/j.athoracsur.2003.10.082</mixed-citation></ref><ref id="scirp.71857-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Isowa, N., Hasegawa, S., Bando, T. and Wada, H. (2002) Preoperative Risk Factors for Prolonged Air Leak Following Lobectomy or Segmentectomy for Primary Lung Cancer. European Journal Cardio-Thoracic Surgery, 73, 1727-1731.</mixed-citation></ref><ref id="scirp.71857-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Abholda, A., Liu, D., Brooks, A. and Burt, M. (1998) Prolonged Air Leak Following Radical Upper Lobectomy: An Analysis of Incidence and Possible Risk Factors. Chest, 113, 1507-1510. http://dx.doi.org/10.1378/chest.113.6.1507</mixed-citation></ref><ref id="scirp.71857-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Liang, S., Ivanovic, J., Gilbert, S., Maziak, D.E., Shamji, F.M., Sundaresan, R.S., et al. (2013) Quantifying the Incidence and Impact of Postoperative Prolonged Alveolar Air Leak after Pulmonary Resection. Journal of Thoracic and Cardiovascular Surgery, 145, 948-954.  
http://dx.doi.org/10.1016/j.jtcvs.2012.08.044</mixed-citation></ref><ref id="scirp.71857-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Bardell, T. and Petsikas, D. (2003) What Keeps Postpulmonary Resection Patients in Hospital? Canadian Respiratory Journal, 10, 86-89.  
http://dx.doi.org/10.1155/2003/610570</mixed-citation></ref><ref id="scirp.71857-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Cerfolio, R.J., Bass, C.S., Pask, A.H. and Katholi, C.R. (2002) Predictors and Treatment of Persistent Air Leaks. Annals of Thoracic Surgery, 73, 1727-1730. 
http://dx.doi.org/10.1016/S0003-4975(02)03531-2</mixed-citation></ref><ref id="scirp.71857-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Stolz, A.J., Schutzner, J., Lischke, R., Simonek, J. and Pafko, P. (2005) Predictors of Prolonged Air Leak Following Pulmonary Lobectomy. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery, 27, 334-336. http://dx.doi.org/10.1016/j.ejcts.2004.11.004</mixed-citation></ref><ref id="scirp.71857-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Lee, L., Hanley, S.C., Robineau, S.C., Sirois, C., Mulder, D.S. and Ferri, L.E. (2011) Estimating the Risk of Prolonged Air Leak after Pulmonary Resection Using a Simple Scoring System. Journal of the American College of Surgeons, 212, 1027-1032. 
http://dx.doi.org/10.1016/j.jamcollsurg.2011.03.010</mixed-citation></ref><ref id="scirp.71857-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Brunelli, A., Varela, G., Refai, M., Jimenez, M.F., Pompili, C., Sabbatini, A. and Aranda, J.L. (2010) A Scoring System to Predict the Risk of Prolonged Air Leak after Lobectomy. Annals of Thoracic Surgery, 90, 204-209.  
http://dx.doi.org/10.1016/j.athoracsur.2010.02.054</mixed-citation></ref><ref id="scirp.71857-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Rivera, C., Bernard, A., Falcoz, P.E., Thomas, P., Schmidt, A., Bénard, S., Vicaut, E. and Dahan, M. (2011) Characterization and Prediction of Prolonged Air Leak after Pulmonary Resection: A Nationwide Study Setting up the Index of Prolonged Air Leak. Annals of Thoracic Surgery, 92, 1062-1068. http://dx.doi.org/10.1016/j.athoracsur.2011.04.033</mixed-citation></ref><ref id="scirp.71857-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">DeCamp, M.M., Blackstone, E.H., Naunheim, K.S., et al. (2006) Patient and Surgical Factors Influencing Air Leak after Lung Volume Reduction Surgery: Lessons Learned from the National Emphysema Treatment Trial. Annals of Thoracic Surgery, 82, 197-207.  
http://dx.doi.org/10.1016/j.athoracsur.2006.02.050</mixed-citation></ref><ref id="scirp.71857-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Irshad, K., Feldman, L.S., Chu, V.F., Dorval, J.-F., Baslaim, G. and Morin, J.E. (2002) Causes of Increased Length of Hospitalization on a General Thoracic Surgery Service: A Prospective Observational Study. Canadian Journal of Surgery, 45, 264-268.</mixed-citation></ref><ref id="scirp.71857-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Varela, G., Jimenez, M.F., Novoa, N. and Aranda, J.L. (2005) Estimating Hospital Costs Attributable to Prolonged Air Leak in Pulmonary Lobectomy. European Journal of Cardio-Thoracic Surgery, 27, 329-333. http://dx.doi.org/10.1016/j.ejcts.2004.11.005</mixed-citation></ref><ref id="scirp.71857-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Burt, B.M. and Shrager, J.B. (2015) The Prevention and Management of Air Leaks Following Pulmonary Resection. Thoracic Surgery Clinics, 25, 411-419.  
http://dx.doi.org/10.1016/j.thorsurg.2015.07.002</mixed-citation></ref><ref id="scirp.71857-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Merritt, R.E., Singhal, S. and Shrager, J.B. (2010) Evidence-Based Suggestions for Management of Air Leaks. Thoracic Surgery Clinics, 20, 435-448.  
http://dx.doi.org/10.1016/j.thorsurg.2010.03.005</mixed-citation></ref><ref id="scirp.71857-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Charlson, M.E., Pompei, P., Ales, K.L., et al. (1987) A New Method of Classifying Prognostic Comorbidity in Longitudinal Studies: Development and Validation. Journal of Chronic Diseases, 40, 373-383. http://dx.doi.org/10.1016/0021-9681(87)90171-8</mixed-citation></ref><ref id="scirp.71857-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Birim, O., Maat, A.P., Kappetein, A.P., et al. (2003) Validation of the Charlson Comorbidity Index in Patients with Operated Primary Non-Small Cell Lung Cancer. European Journal of Cardio-Thoracic Surgery, 23, 30-34. http://dx.doi.org/10.1016/S1010-7940(02)00721-2</mixed-citation></ref><ref id="scirp.71857-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Stenton, C. (2008) The MRC Breathlessness Scale. Occupational Medicine, 58, 226-227.  
http://dx.doi.org/10.1093/occmed/kqm162</mixed-citation></ref><ref id="scirp.71857-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Oken, M.M., Creech, R.H., Tormey, D.C., et al. (1982) Toxicity and Response Criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology, 5, 649-655. http://dx.doi.org/10.1097/00000421-198212000-00014</mixed-citation></ref></ref-list></back></article>